Targeting IFN-alpha, RANK-RANKL, and CD40-CD40L system could also be beneficial for the prevention and early therapeutic intervention in psoriasis and other related autoimmune diseases [30, 34, 35, 38]. This evidence concerns the gene CD40 and autoimmune disease.